News Attana AB

Equities

ATANA

SE0010547273

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
0.082 ^SEK	-1.20%		+17.14%	-17.17%

Feb. 22	Attana AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
2023	Attana Lands Order for Kinetic Interaction Analysis of Tissue in US	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

New paper using Attana tecnology to understand how viruses enter human cells	Apr. 01	AQ
One of US leading health institutes has placed an order for an upgrade of an existing instrument, valued at $150k	Mar. 05	AQ
Attana AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 22	CI
New paper using Attana Technology to study structures on surface in Ion Liquids demonstrating the effect of surface charges on interaction properties.	Feb. 13	AQ
New publication using Attana technology towards environmentally friendly and financially viable methods to create functional materials	Jan. 23	AQ
New article using Attana's technology from National University of Singapore: Immunity differences in vaccinated individuals according to age, gender, lifestyle and other diseases	Dec. 20	AQ
Biosensors to characterize immune response to bacterial diseases	Dec. 18	AQ
Attana and Linnaeus University have published the first part of the science behind immunity profiles	Dec. 05	AQ
Attana Lands Order for Kinetic Interaction Analysis of Tissue in US	Dec. 04	MT
Breakthrough order with new customer in the USA	Dec. 04	AQ
Attana AB Receives Breakthrough Order with New Customer in the USA	Dec. 04	CI
Strengthened collaboration with European biotech customer who extends their service and support agreement for another 12 months.	Nov. 23	AQ
Customer Develops Therapeutic Antibodies Against Cancer and Uses Attana's Cell-Based Technology	Nov. 23	CI
A new publication using Attana Technology from National University of Singapore examining the neutralization capacity of human IgG antibodies agsinst different mutations of the SARS-CoV-2	Nov. 20	AQ
Robust QCM-Based Sensing and Assay Formats in Commercialized Systems	Nov. 15	AQ
Attana AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-26	CI
Dear shareholders and valuable followers,	23-10-04	AQ
New publication that shows the strength of Attana's offering in diagnostics, here applied in veterinary medicine.	23-09-26	AQ
Attana Announces CEO Changes	23-09-18	CI
New publication from National University of Singapore using Attana Technology to study Immune Response from Tuberculosis Exposed Healthy Individuals	23-09-06	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Attana AB

Equities

ATANA

SE0010547273

Summary

Filters